血钙升高伴甲状旁腺激素≤50 pg/mL是否应诊断原发性甲状旁腺功能亢进
该研究回顾2000至2021年共2,349例因原发性甲状旁腺功能亢进接受甲状旁腺切除术的患者,其中149例术前甲状旁腺激素≤50.0 pg/mL。这些患者均存在异常细胞增多的甲状旁腺,治愈率96.7%,且多腺体病变比例更高,作者认为应考虑手术并可行双侧探查。
要点
- 血钙升高伴甲状旁腺激素≤50.0 pg/mL仍可能是原发性甲状旁腺功能亢进
- 此类患者多腺体病变比例高(58.9%),宜考虑双侧甲状旁腺探查
- 手术治愈率与甲状旁腺激素>50.0 pg/mL者无差异(96.7%)
核心结论
- 血钙升高且甲状旁腺激素≤50 pg/mL的患者临床表现和手术治愈率与其他原发性甲状旁腺功能亢进患者相似,应考虑甲状旁腺切除术。
研究设计与样本
- 单中心回顾性队列,2000至2021年共2,349例因原发性甲状旁腺功能亢进接受甲状旁腺切除术,其中149例术前甲状旁腺激素≤50.0 pg/mL,并与甲状旁腺激素>50.0 pg/mL者比较。
主要发现
- 甲状旁腺激素≤50组中位甲状旁腺激素40.0 pg/mL(范围11.6-50.0 pg/mL),全部患者均发现异常细胞增多的甲状旁腺,治愈率96.7%。
- 与甲状旁腺激素>50组相比,≤50组更年轻(56±15 vs 60±14岁,P<.001)、体重指数更低(28.7±7.0 vs 31.2±7.9 kg/m2,P<.001)。
- ≤50组乏力比例更高(73.2% vs 63.0%,P=.033),多腺体病变比例更高(58.9% vs 31.9%,P<.001)。
- 两组在人口学特征、既往甲状旁腺手术史、手术治愈率及术后并发症(持续性或复发性甲状旁腺功能亢进及低钙血症)方面无差异。
关键数值与推荐
- 甲状旁腺激素正常参考范围12.0-88.0 pg/mL,本研究以≤50.0 pg/mL界定为甲状旁腺激素≤50组。
- 甲状旁腺激素≤50组多腺体病变比例为58.9%,高于>50组的31.9%(P<.001)。
- 甲状旁腺激素≤50组手术治愈率为96.7%。
临床怎么用
- 对血钙升高且甲状旁腺激素≤50.0 pg/mL者不应仅因激素数值在参考范围内而排除原发性甲状旁腺功能亢进,应评估手术指征。
- 此类患者多腺体病变可能性较高,术前应做好双侧甲状旁腺探查的准备。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Primary hyperparathyroidism is characterized by hypercalcemia with inappropriately normal or elevated parathyroid hormone. However, the absolute parathyroid hormone value that is defined as inappropriately normal is unclear. We reviewed our experience with parathyroidectomy in patients with hypercalcemia and parathyroid hormone of ≤50.0 pg/mL (normal range 12.0-88.0 pg/mL). METHODS: A total of 2,349 patients underwent parathyroidectomy for primary hyperparathyroidism between 2000 and 2021. Of these, 149 patients had preoperative parathyroid hormone ≤50.0 pg/mL (parathyroid hormone ≤50). The biology and outcomes were compared to patients with parathyroid hormone >50.0 pg/mL (parathyroid hormone >50). RESULTS: Of the parathyroid hormone ≤50 patients, the median parathyroid hormone was 40.0 pg/mL (range 11.6-50.0 pg/mL). All patients were found to have abnormal hypercellular parathyroid glands with a cure rate of 96.7%. When compared to the parathyroid hormone >50 group, the parathyroid hormone ≤50 group was younger (56 ± 15 vs 60 ± 14 years, P < .001) with a lower body mass index (28.7 ± 7.0 kg/m2 vs 31.2 ± 7.9 kg/m2, P < .001), higher rate of fatigue (73.2% vs 63.0%, P = .033), and higher rate of multiglandular disease (58.9% vs 31.9%, P < .001). There was no difference between the groups with respect to patient demographics, rate of previous parathyroidectomy, surgical cure, or postoperative complications (persistent or recurrent hyperparathyroidism and hypocalcemia). CONCLUSION: Patients with hypercalcemia and parathyroid hormone ≤50 pg/mL have a similar clinical presentation and rate of surgical cure to other primary hyperparathyroidism patients and should be considered for parathyroidectomy. Most of these patients have multiglandular disease and thus should be considered for bilateral parathyroid exploration.
引用
- Wang R, Abraham P, Fazendin J, et al. Hypercalcemia with a parathyroid hormone level of ≤50 pg/mL: Is this primary hyperparathyroidism? Surgery. 2022. PMID: 36202653. doi:10.1016/j.surg.2022.05.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。